NMR Experiment |
---|
Experiment | Type | Sample Contents | Solvent | Ionic Strength | pH | Pressure | Temperature (K) | Spectrometer |
---|
1 | 2D 1H-15N HSQC | 0.36 mM [U-13C; U-15N] Myosin VI 1050-1131, 0.36 mM None Clathrin Light Chain Alpha 46-61 | 95% H2O/5% D2O | 50 mM NaCl, 20 mM NaPO4 mM | 6.5 | 760 mmHg | 283.2 | Bruker AVANCE III 850 |
2 | 3D 1H-15N NOESY | 0.36 mM [U-13C; U-15N] Myosin VI 1050-1131, 0.36 mM None Clathrin Light Chain Alpha 46-61 | 95% H2O/5% D2O | 50 mM NaCl, 20 mM NaPO4 mM | 6.5 | 760 mmHg | 283.2 | Bruker AVANCE III 850 |
3 | 2D 1H-13C HSQC | 0.36 mM [U-13C; U-15N] Myosin VI 1050-1131, 0.36 mM None Clathrin Light Chain Alpha 46-61 | 95% H2O/5% D2O | 50 mM NaCl, 20 mM NaPO4 mM | 6.5 | 760 mmHg | 283.2 | Bruker AVANCE III 850 |
4 | 3D 1H-13C NOESY | 0.36 mM [U-13C; U-15N] Myosin VI 1050-1131, 0.36 mM None Clathrin Light Chain Alpha 46-61 | 95% H2O/5% D2O | 50 mM NaCl, 20 mM NaPO4 mM | 6.5 | 760 mmHg | 283.2 | Bruker AVANCE III 850 |
5 | 2D 1H-15N HSQC | 0.4 mM None Myosin VI 1050-1131, 0.4 mM [U-13C; U-15N] Clathrin Light Chain Alpha 46-61 | 95% H2O/5% D2O | 50 mM NaCl, 20 mM NaPO4 mM | 6.5 | 760 mmHg | 283.2 | Bruker AVANCE III 850 |
9 | 3D 1H-15N NOESY | 0.4 mM None Myosin VI 1050-1131, 0.4 mM [U-13C; U-15N] Clathrin Light Chain Alpha 46-61 | 95% H2O/5% D2O | 50 mM NaCl, 20 mM NaPO4 mM | 6.5 | 760 mmHg | 283.2 | Bruker AVANCE III 850 |
8 | 2D 1H-13C HSQC | 0.4 mM None Myosin VI 1050-1131, 0.4 mM [U-13C; U-15N] Clathrin Light Chain Alpha 46-61 | 95% H2O/5% D2O | 50 mM NaCl, 20 mM NaPO4 mM | 6.5 | 760 mmHg | 283.2 | Bruker AVANCE III 850 |
7 | 3D 1H-13C NOESY | 0.4 mM None Myosin VI 1050-1131, 0.4 mM [U-13C; U-15N] Clathrin Light Chain Alpha 46-61 | 95% H2O/5% D2O | 50 mM NaCl, 20 mM NaPO4 mM | 6.5 | 760 mmHg | 283.2 | Bruker AVANCE III 850 |
6 | 3D HNCO | 0.36 mM [U-13C; U-15N] Myosin VI 1050-1131, 0.36 mM None Clathrin Light Chain Alpha 46-61 | 95% H2O/5% D2O | 50 mM NaCl, 20 mM NaPO4 mM | 6.5 | 760 mmHg | 283.2 | Bruker AVANCE III 700 |
10 | 3D HNCACB | 0.36 mM [U-13C; U-15N] Myosin VI 1050-1131, 0.36 mM None Clathrin Light Chain Alpha 46-61 | 95% H2O/5% D2O | 50 mM NaCl, 20 mM NaPO4 mM | 6.5 | 760 mmHg | 283.2 | Bruker AVANCE III 850 |
12 | 3D HNCO | 0.4 mM None Myosin VI 1050-1131, 0.4 mM [U-13C; U-15N] Clathrin Light Chain Alpha 46-61 | 95% H2O/5% D2O | 50 mM NaCl, 20 mM NaPO4 mM | 6.5 | 760 mmHg | 283.2 | Bruker AVANCE III 850 |
11 | 3D HNCACB | 0.4 mM None Myosin VI 1050-1131, 0.4 mM [U-13C; U-15N] Clathrin Light Chain Alpha 46-61 | 95% H2O/5% D2O | 50 mM NaCl, 20 mM NaPO4 mM | 6.5 | 760 mmHg | 283.2 | Bruker AVANCE III 850 |
13 | half-filtered 3D 1H-13C NOESY | 0.36 mM [U-13C; U-15N] Myosin VI 1050-1131, 0.36 mM None Clathrin Light Chain Alpha 46-61 | 95% H2O/5% D2O | 50 mM NaCl, 20 mM NaPO4 mM | 6.5 | 760 mmHg | 283.2 | Bruker AVANCE III 850 |
14 | half-filtered 3D 1H-13C NOESY | 0.4 mM None Myosin VI 1050-1131, 0.4 mM [U-13C; U-15N] Clathrin Light Chain Alpha 46-61 | 95% H2O/5% D2O | 50 mM NaCl, 20 mM NaPO4 mM | 6.5 | 760 mmHg | 283.2 | Bruker AVANCE III 850 |